Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors

This study has been completed.

Study NCT00079352 Information provided by National Cancer Institute (NCI)

First Received: March 8, 2004 Last Updated: October 13, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	October 2007 (Final data collection date for primary outcome measure)

Publications:

Fekrazad HM, Verschraegen CF, Royce M, Smith HO, Chyi Lee F, Rabinowitz I. A phase I study of flavopiridol in combination with gemcitabine and irinotecan in patients with metastatic cancer. Am J Clin Oncol. 2010 Aug;33(4):393-7.

Rabinowitz I, Verschraegen CF, Lee FC, et al.: A phase 1 study of flavopiridol in combination with gemcitabine and irinotecan in patients with metastatic cancer. [Abstract] J Clin Oncol 24 (Suppl 18): A-13099, 609s, 2006.